LU84530A1 - Procede de preparation d'acide p-butoxyphenylacethydroxamique a l'etat finement divise et composition contenant cet acide - Google Patents

Procede de preparation d'acide p-butoxyphenylacethydroxamique a l'etat finement divise et composition contenant cet acide Download PDF

Info

Publication number
LU84530A1
LU84530A1 LU84530A LU84530A LU84530A1 LU 84530 A1 LU84530 A1 LU 84530A1 LU 84530 A LU84530 A LU 84530A LU 84530 A LU84530 A LU 84530A LU 84530 A1 LU84530 A1 LU 84530A1
Authority
LU
Luxembourg
Prior art keywords
acid
solution
butoxyphenylacethydroxamic
preparation
precipitating
Prior art date
Application number
LU84530A
Other languages
English (en)
French (fr)
Inventor
Georges Lambelin
Michel Franz
Andras Vincze
Alain Polat
Original Assignee
Midit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19730000&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU84530(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Midit filed Critical Midit
Priority to LU84530A priority Critical patent/LU84530A1/fr
Priority to JP58010017A priority patent/JPS59110655A/ja
Priority to DE8383201719T priority patent/DE3365914D1/de
Priority to EP83201719A priority patent/EP0116182B2/fr
Priority to AT83201719T priority patent/ATE21889T1/de
Priority to US06/558,885 priority patent/US4534911A/en
Priority to CA000443104A priority patent/CA1218675A/en
Publication of LU84530A1 publication Critical patent/LU84530A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU84530A 1982-12-13 1982-12-13 Procede de preparation d'acide p-butoxyphenylacethydroxamique a l'etat finement divise et composition contenant cet acide LU84530A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
LU84530A LU84530A1 (fr) 1982-12-13 1982-12-13 Procede de preparation d'acide p-butoxyphenylacethydroxamique a l'etat finement divise et composition contenant cet acide
JP58010017A JPS59110655A (ja) 1982-12-13 1983-01-26 ｐ−ブトキシフェニルアセチルヒドロキサム酸の製造方法
DE8383201719T DE3365914D1 (en) 1982-12-13 1983-12-05 Process for the preparation of finely divided p-butoxyphenyl acethydroxamic acid, and compositions containing them
EP83201719A EP0116182B2 (fr) 1982-12-13 1983-12-05 Procédé de préparation d'acide p-butoxyphénylacéthydroxamique à l'état finement divisé
AT83201719T ATE21889T1 (de) 1982-12-13 1983-12-05 Verfahren zur herstellung von fein zerteilter p- butoxyphenylacethydroxamsaeure und die sie enthaltenden zusammensetzungen.
US06/558,885 US4534911A (en) 1982-12-13 1983-12-07 Method for the preparation of p-butoxyphenylacetyl-hydroxamic acid in the finely divided state and a composition containing this acid
CA000443104A CA1218675A (en) 1982-12-13 1983-12-12 Method for the preparation of p- butoxyphenylacetylhydroxamic acid in the finely divided state and a composition containing this acid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU84530A LU84530A1 (fr) 1982-12-13 1982-12-13 Procede de preparation d'acide p-butoxyphenylacethydroxamique a l'etat finement divise et composition contenant cet acide
LU84530 1982-12-13

Publications (1)

Publication Number Publication Date
LU84530A1 true LU84530A1 (fr) 1984-10-22

Family

ID=19730000

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84530A LU84530A1 (fr) 1982-12-13 1982-12-13 Procede de preparation d'acide p-butoxyphenylacethydroxamique a l'etat finement divise et composition contenant cet acide

Country Status (7)

Country Link
US (1) US4534911A (es)
EP (1) EP0116182B2 (es)
JP (1) JPS59110655A (es)
AT (1) ATE21889T1 (es)
CA (1) CA1218675A (es)
DE (1) DE3365914D1 (es)
LU (1) LU84530A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130160B1 (en) * 1983-06-22 1988-01-07 The Ohio State University Research Foundation Small particle formation
DE3604050A1 (de) * 1986-02-08 1987-08-13 Boehringer Mannheim Gmbh Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
JPS63130891A (ja) * 1986-11-19 1988-06-03 東洋シャッター株式会社 安全シヤツタ−
EP0885609A1 (en) * 1997-06-17 1998-12-23 Continental Pharma Incorporated Use of a pharmaceutical composition in the treatment of traumatic arthritis in horses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE600278A (fr) * 1960-02-18 1961-08-16 Basf Ag Procédé pour la production de N-aryl-N'-hydroxy-urées.
SU390074A1 (ru) * 1970-08-04 1973-07-11 Всесоюзный научно исследовательский , проектный институт механической обработки полезных ископаемых Способ получения алкилгидроксамовых
SU632690A1 (ru) * 1977-06-08 1978-11-15 Предприятие П/Я М-5245 Способ получени с7-с9-алкилгидроксамовых кислот
JPS5777646A (en) * 1980-10-31 1982-05-15 Kanto Kagaku Kk Preparation of hydroxamic acid

Also Published As

Publication number Publication date
EP0116182A1 (fr) 1984-08-22
DE3365914D1 (en) 1986-10-09
EP0116182B2 (fr) 1989-12-27
ATE21889T1 (de) 1986-09-15
JPS6121618B2 (es) 1986-05-28
JPS59110655A (ja) 1984-06-26
EP0116182B1 (fr) 1986-09-03
CA1218675A (en) 1987-03-03
US4534911A (en) 1985-08-13

Similar Documents

Publication Publication Date Title
EP0078785B1 (fr) Sels d'acide valproîque, leur préparation et leur utilisation
EP0608207B1 (fr) Compositions pharmaceutiques contenant des nanocapsules
EP0233853B1 (fr) Couples effervescents, compositions effervescentes d'antagonistes H2 de l'histamine les contenant et leur préparation
CA1220718A (fr) Composition pharmaceutique a base d'acide valproique et son procede de fabrication
FR2615101A1 (fr) Composition pharmaceutique a base de cefuroxime axetil et sa preparation
WO1997004749A1 (fr) Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
CH667271A5 (fr) Nedocromil sodique solide contenant de l'eau combinee et composition pharmaceutique le contenant.
CH646412A5 (fr) Procede de preparation des produits hydrosolubles a base de (+)-catechine et compositions contenant ces produits.
EP0614362B1 (fr) Compositions pharmaceutiques a base d'ebastine ou de ses analogues
EP0116182B1 (fr) Procédé de préparation d'acide p-butoxyphénylacéthydroxamique à l'état finement divisé
CA2627608A1 (fr) Azodicarbonamide micronise, sa preparation et son utilisation
WO2012059689A1 (fr) Poudre de polysaccharide et de polyol, comprimable et de haute viscosite
CA2354574C (fr) Troxerutine a forte teneur en trihydroxy-ethyl-rutoside et procede de preparation
WO2019171009A1 (fr) Formulation gastro-protégée et hydrophobe d'au moins un principe actif et procédé d'obtention
EP3148961B1 (fr) Procédé de préparation d'un sel d'acide acétylsalicylique et d'un acide aminé basique
FR2660555A1 (fr) Gelule huileuse de ketoprofene.
EP0036345B1 (fr) Nouveau procédé d'enrobage d'au moins un principe actif médicamenteux, les nouveaux médicaments ainsi obtenus, et les compositions les renfermant
EP2885265A1 (fr) Procede de fabrication de compositions riches en cristaux de mannitol sous forme delta, compositions et cristaux obtenus ainsi que leurs utilisations
FR2470765A1 (fr) Nouveaux sels d'addition d'acides du 4'-(9-acridinyl-amino)methanesulf-m-anisidide, leur procede de production et composition pharmaceutique les contenant
FR2882655A1 (fr) Nouveau procede d'obtention d'une poudre d'imidapril a dissolution rapide
BE887220A (fr) Compositions antitumeurs
FR2995896A1 (fr) Forme amorphe stabilisee de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent.
EP0236230A1 (fr) Suspensions aqueuses contenant au moins un composé choisi parmi les acides 6,7-dihydro-benzoquinolizine-carboxyliques, et leurs applications pour le traitement des végétaux
BE806838A (fr) Nouvelles compositions pharmaceutiques a base de n-4-(2-(5-chloro-2-methoxybenzamido)-ethyl)phenylsulfonyl-n'-cyclohexyl-uree et de ses sels et leur procede de preparation
EP0066934A1 (fr) Sels de nitrofurantoine, leur préparation et leur utilisation

Legal Events

Date Code Title Description
TP Transfer of rights

Free format text: 860109 CONTINENTAL PHARMA INC. BRUXELLES